Kaplan–Meier survival curve analysis demonstrated a significant association between high VAX2 expression and reduced overall survival (OS, Supplementary Fig. 2B1) and disease-specific survival (DSS, Supplementary Fig. 2B2) in a considerable cohort of patients with GC (https://portal.gdc.cancer.gov/projects/). The gene discussed is VAX2; the disease is gastric cancer.